EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Biased GLP‐2 agonist with strong G protein‐coupling but impaired arrestin recruitment and receptor desensitization enhances intestinal growth in mice

Maria Buur Nordskov Gabe, Liv von Voss, Jenna Elizabeth Hunt, Sarina Gadgaard, Laerke Smidt Gasbjerg, Jens Juul Holst, Hannelouise Kissow, Bolette Hartmann, Mette Marie Rosenkilde iD

British Journal of Pharmacology · 2023

DOI: 10.1111/bph.16040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2023. Verfasst von Maria Buur Nordskov Gabe und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Glucagon-Like Peptide 2, Arrestin. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Det Sundhedsvidenskabelige Fakultet, Københavns Universitet, Kirsten og Freddy Johansens Fond, Novo Nordisk Fonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Glucagon‐like peptide‐2 (GLP‐2) is secreted postprandially by enteroendocrine L‐cells and stimulates growth of the gut and bone. One GLP‐2 analogue is approved for short bowel syndrome (SBS). To improve therapeutic efficacy, we developed biased GLP‐2 receptor (GLP‐2R) agonists through N‐terminal modifications. Experimental Approach Variants with Ala and Trp substitutions of the first seven positions of GLP‐2(1‐33) were studied in vitro for affinity, G protein activation (cAMP accumulation), recruitment of β‐arrestin 1 and 2, and internalization of the human and mouse GLP‐2R. The intestinotrophic actions of the most efficacious (cAMP) biased variant were examined in mice. Key Results Ala substitutions had more profound effects than Trp substitutions. For both, alterations at positions 1, 3 and 6 most severely impaired activity. β‐arrestin recruitment was more affected than cAMP accumulation. Among Ala substitutions, [H1A], [D3A] and [F6A] impaired potency (EC 50 ) for cAMP‐accumulation >20‐fold and efficacy (E max ) to 48%–87%, and were unable to recruit arrestins. The Trp substitutions, [A2W], [D3W] and [G4W] were partial agonists (E max of 46%–59%) with 1.7–12‐fold decreased potencies in cAMP and diminished β‐arrestin recruitment. The biased variants, [F6A], [F6W] and [S7W] induced less GLP‐2R internalization compared with GLP‐2, which induced internalization in a partly arrestin‐independent manner. In mice, [S7W] enhanced gut trophic actions with increased weight of the small intestine, increased villus height and crypt depth compared with GLP‐2. Conclusion and Implications G protein‐biased GLP‐2R agonists with diminished receptor desensitization have superior intestinotrophic effects and may represent improved treatment of intestinal insufficiency including SBS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide 2ArrestinMiceHumansAnimalsGTP-Binding Proteinsbeta-ArrestinsArrestinsbeta-Arrestin 1Glucagon-Like Peptide-1 Receptor

Stichwörter der Autor:innen

GLP-2 receptor (GLP-2R)biasglucagon-like peptide-2 (GLP-2)internalizationintestinal growth

Substanzen

Glucagon-Like Peptide 2ArrestinGTP-Binding Proteinsbeta-ArrestinsArrestinsbeta-Arrestin 1Glucagon-Like Peptide-1 Receptor

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Mette Marie Rosenkilde

Förderung

  • Det Sundhedsvidenskabelige Fakultet, Københavns Universitet
  • Kirsten og Freddy Johansens Fond
  • Novo Nordisk Fonden

Zitieren

APA

Gabe, M. B. N., von Voss, L., Hunt, J. E., Gadgaard, S., Gasbjerg, L. S., Holst, J. J., Kissow, H., Hartmann, B., & Rosenkilde, M. M. (2023). Biased GLP‐2 agonist with strong G protein‐coupling but impaired arrestin recruitment and receptor desensitization enhances intestinal growth in mice. British Journal of Pharmacology. https://doi.org/10.1111/bph.16040

Vancouver

Gabe MBN, von Voss L, Hunt JE, Gadgaard S, Gasbjerg LS, Holst JJ, et al. Biased GLP‐2 agonist with strong G protein‐coupling but impaired arrestin recruitment and receptor desensitization enhances intestinal growth in mice. British Journal of Pharmacology. 2023. doi:10.1111/bph.16040

BibTeX
@article{Gabe2023,
  author = {Gabe, Maria Buur Nordskov and von Voss, Liv and Hunt, Jenna Elizabeth and Gadgaard, Sarina and Gasbjerg, Laerke Smidt and Holst, Jens Juul and Kissow, Hannelouise and Hartmann, Bolette and Rosenkilde, Mette Marie},
  title = {Biased GLP‐2 agonist with strong G protein‐coupling but impaired arrestin recruitment and receptor desensitization enhances intestinal growth in mice},
  journal = {British Journal of Pharmacology},
  year = {2023},
  doi = {10.1111/bph.16040}
}
Kostenlos starten →